peptideNot FDA-approvedResearch chemicalNot an FDA- or EMA-approved drugNo published human trials; evidence is limited to rat models and isolated-DNA/cell work
BronchogenBenefits, Dosage & Interactions
Bronchogen is a synthetic peptide known as a bioregulator, specifically designed to support the respiratory system. It belongs to a class of compounds developed in Russia by Professor V. Research on Bronchogen focuses on healthy aging. Dose, response, and interaction risk vary by individual, so use should be reviewed with a clinician.
Researched by DoseRoutine Research TeamReviewed for accuracy by Nicholas Alexander, RSE, SO, PMPLast updated Educational reference only — not medical advice. Always confirm dosing and safety decisions with a licensed clinician.
Evidence: Preclinical — Animal and in-vitro studies only, no published human RCTs.
Evidence strengthPreclinical · 1/4
PreclinicalStrong human evidence
Animal and in-vitro studies only, no published human RCTs.
Plasma half-life
Not established
Default unit
mg
Mixing Bronchogen: bacteriostatic water and syringe units
The vial arrives as dry powder. How much water you add sets the strength, and the strength sets the mark you draw to on the syringe. The table assumes a 5 mg vial and a 250 mcg example draw on a U-100 insulin syringe, where 100 units is one millilitre. If your vial is a different size, scale it — the arithmetic is the same.
| Bacteriostatic water added | Resulting strength | 250 mcg draws to |
|---|---|---|
| 1 mL | 5 mg/mL | 5 units |
| 2 mL | 2.5 mg/mL | 10 units |
| 3 mL | 1.67 mg/mL | 15 units |
Units, not millilitres. Insulin syringes are marked in units, and mixing up mcg and mg on a peptide label is the single most common error people report. Check the label twice. Run your own vial through the calculator.
Storage and stability
- Before mixing
- Sealed and still as a dry powder, Bronchogen vials are normally kept in the fridge at 2–8 °C, out of light. Short spells at room temperature during shipping are the norm for lyophilized peptides and are not, on their own, a sign the vial is spoiled.
- After mixing
- Once bacteriostatic water goes in, the vial belongs in the fridge and is generally treated as good for about 28 days — that is how long the benzyl alcohol in bacteriostatic water is relied on to hold back bacterial growth. Plain sterile water has no preservative, so a vial mixed with it is a single-session vial. Never freeze a reconstituted vial.
- When to throw it out
- A properly mixed vial is clear. Cloudiness, floating strands, a color change or powder that will not go into solution after gentle swirling all mean the vial should be discarded rather than used. Shaking a peptide vial hard is the usual cause — swirl it, or run the water down the inside wall of the vial instead of onto the powder.
Handling and shelf-life figures describe general practice for lyophilized peptides. They are not a dose and not medical advice — your prescriber or the product label sets the amount.
References & evidence
Documents the Bronchogen entry is written from. Each number matches an inline marker above.
- [1]Effect of the peptide bronchogen (Ala-Asp-Glu-Leu) on DNA thermostabilityMonaselidze JR, Khavinson VKh, Gorgoshidze MZ, et al. · Bulletin of Experimental Biology and Medicine · 2011 · Peer-reviewed · PMID 21240358
- [2]Modulating Effect of Peptide Therapy on the Morphofunctional State of Bronchial Epithelium in Rats with Obstructive Lung PathologyKuzubova NA, Lebedeva ES, Dvorakovskaya IV, et al. · Bulletin of Experimental Biology and Medicine · 2015 · Peer-reviewed · PMID 26468022
References & Evidence
Sources on this page that document Bronchogen dosing, timing and safety.
- [1]National Center for Biotechnology Information View source
Educational information only — not medical advice. Dose ranges vary by person, indication and prescriber.
What is Bronchogen studied for?
What is Bronchogen?Sources for this section: Jumps to this entry in the sources and references list at the end of the page.
Bronchogen is a synthetic peptide known as a bioregulator, specifically designed to support the respiratory system. It belongs to a class of compounds developed in Russia by Professor V. Khavinson, which are theorized to restore normal cellular function by interacting with DNA. Peptides, as short chains of amino acids, play diverse roles in biological systems, including acting as signaling molecules. Bronchogen is derived from bovine tracheal tissue, meaning it is a xenogenic peptide bioregulator. The concept behind bioregulators is that specific peptides can selectively regulate gene expression in corresponding tissues, thereby promoting regeneration and maintaining tissue homeostasis. In the case of Bronchogen, its primary focus is on the bronchial tree and lung tissue. It is posited to normalize the function of respiratory cells and support the overall health of the pulmonary system. While its primary association is with respiratory health, interest in bioregulators like Bronchogen has extended to broader applications, including anti-aging and longevity discussions, based on the idea of restoring optimal cellular function across various organ systems. It is typically available as an oral supplement. (Source: Research literature, notably from the Khavinson Institute)
What does the research say about Bronchogen?
Tap a section to expand.
Bronchogen's proposed mechanism of action is based on the theory of peptide bioregulation. This theory suggests that short-chain peptides, like Bronchogen, can act as epigenetic regulators. They are thought to bind to specific DNA regions within target cells, influencing gene expression without altering the DNA sequence itself. This interaction is believed to normalize protein synthesis in the cells of the bronchial tree and lung tissue. By stimulating the synthesis of specific proteins, Bronchogen is hypothesized to restore the functional activity of these cells, thereby improving their resilience and regenerative capacity. The selectivity of Bronchogen is attributed to its specific amino acid sequence, which is believed to enable it to target respiratory epithelial cells specifically. This targeted action is proposed to help maintain cellular homeostasis and mitigate age-related or stress-induced cellular dysfunction within the respiratory system. The precise molecular pathways and specific genes influenced are subjects of ongoing research. (Source: Research by Khavinson and colleagues, various scientific publications)
Source for this section: Sources for How does Bronchogen work?: Jumps to this entry in the sources and references list at the end of the page.
Current research and theoretical frameworks suggest that Bronchogen offers several potential benefits, primarily related to respiratory health and, by extension, general cellular well-being. Its primary proposed benefit is the support of bronchial and lung function. This includes potentially enhancing the regenerative capacity of respiratory tissues, which may be beneficial in conditions involving cellular damage or stress within the lungs. By normalizing protein synthesis in respiratory cells, Bronchogen is theorized to improve the overall resilience and functional integrity of the respiratory system. Some proponents suggest it may contribute to maintaining healthy lung architecture and function, potentially protecting against age-related decline in respiratory capacity. Due to the broader theory of peptide bioregulation impacting cellular health, there is also an extrapolated interest in Bronchogen's potential role in longevity strategies, posited through its contribution to systemic cellular vitality. However, direct evidence for broad longevity effects specifically from Bronchogen in humans is limited. (Source: Research literature concerning peptide bioregulators, such as studies published in various scientific journals reviewing the Khavinson peptides)
Evidence for Bronchogen primarily stems from studies conducted in Russia and Eastern Europe, often associated with the work of Professor V. Khavinson and his institute. These studies frequently involve animal models and human observational or small-scale interventional trials. For instance, some research has indicated that Bronchogen may have a restorative effect on the structure and function of the bronchial mucosa and lung parenchyma in animal models subjected to various stressors, such as exposure to toxins or radiation. In human studies, particularly among individuals with compromised respiratory function, Bronchogen has been investigated for its potential to improve parameters related to lung health, such as vital capacity and subjective well-being. These studies often report positive outcomes, including improved respiratory function and reduced frequency of exacerbations in chronic conditions. However, it is important to note that many of these studies are not widely replicated in Western scientific literature, and often lack the large-scale, double-blind, placebo-controlled designs that are standard for pharmaceutical development and widespread acceptance. While promising, the evidence base is still developing and requires further rigorous investigation according to international scientific standards to fully substantiate its claims for efficacy and safety across diverse populations. (Source: Various peer-reviewed articles from Russian and Eastern European scientific journals, often cited in reviews of peptide bioregulators; general research literature on peptide pharmacology)
Information on the side effects of Bronchogen is limited in published literature, particularly within Western medical databases. Studies conducted in Russia and Eastern Europe often report that peptide bioregulators like Bronchogen have a favorable safety profile with minimal reported side effects. When side effects are mentioned, they are typically described as mild and transient, though specific details are often scarce. As with any compound, individual reactions can vary. Any observed adverse reactions should be reported to a healthcare professional.
This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Bronchogen is generally considered to have a low toxicity profile based on available research, predominantly from its origin country. However, as with any bioactive substance, certain precautions should be considered. Individuals with known allergies to bovine-derived products should exercise caution, as Bronchogen is xenogenic (derived from animal tissue). Pregnant or breastfeeding individuals should avoid use due to insufficient data on safety in these populations. Individuals with pre-existing medical conditions, particularly those affecting the respiratory system or immune system, should consult a healthcare provider before use. The long-term effects of Bronchogen are not extensively studied in broad populations or over extended periods outside of specific research settings. Product purity and concentration can vary between manufacturers, as this compound is often sold as a dietary supplement; therefore, sourcing from reputable suppliers is important.
This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Given the limited comprehensive data available in international medical literature, specific absolute contraindications for Bronchogen are not as extensively documented as for pharmaceutical drugs. However, based on general pharmacological principles and the nature of this compound, contraindications would likely include hypersensitivity or allergic reactions to the active substance or any excipients. As Bronchogen is derived from animal tissue, individuals with known allergies to animal-derived products, especially bovine, should avoid it. It is also contraindicated in pregnancy and lactation due to the absence of safety data for these critical periods. Children should not use Bronchogen unless specifically directed and monitored by a qualified healthcare professional, again due to a lack of age-specific safety and efficacy data. Always consult a qualified clinician to assess individual suitability and potential risks.
This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Due to the limited comprehensive research on Bronchogen in widely accessible Western scientific databases, there is a scarcity of specific information regarding negative interactions with medications, other supplements, or foods. As a relatively unstudied compound in conventional medical settings, caution is advised when combining it with other treatments. Individuals taking immunosuppressants or medications that affect respiratory function should exercise particular caution and seek medical advice before using Bronchogen, as potential interactions have not been thoroughly investigated. It is always recommended to inform your healthcare provider about all supplements and medications you are currently taking to avoid unforeseen interactions.
This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Bronchogen is typically available in oral capsule form. The label for Bronchogen often recommends a user-directed dose, which refers to a dose that must be set by a licensed clinician. It can be taken with or without food. The half-life of 1.0 hour indicates a relatively rapid elimination from the body, suggesting that if a sustained effect is desired, multiple daily administrations might be necessary, though specific dosing regimens are user-directed and should be determined by a qualified clinician. Because it is not a stimulant or sedative, it can be taken at any time of day, according to a user-directed schedule. (Source: Product information from manufacturers, general half-life principles)
Source for this section: Sources for When should you take Bronchogen?: Jumps to this entry in the sources and references list at the end of the page.
Put it into practice
Reading about Bronchogen is the first step — DoseRoutine helps you act on it. These free tools turn what you just learned into a routine.
What interacts with Bronchogen?
| Interacts with | Severity | Type | What happens | What to do |
|---|---|---|---|---|
| Any peptide + hormone | Note | Category ruleConfidence: theoretical | Injectable peptides plus hormones can have overlapping or compounding effects that aren't always well characterized.Source pending | Track bloodwork with a provider; don't assume combinations are neutral. |
Frequently asked questions about Bronchogen
Bronchogen is a peptide bioregulator, a short chain of amino acids derived from bovine tracheal tissue. It is designed to support the health and function of the respiratory system by purportedly regulating gene expression in lung cells.
Bronchogen is theorized to work by selectively binding to DNA in respiratory cells, influencing gene expression to normalize protein synthesis and restore optimal cellular function in the bronchi and lungs. This is part of the peptide bioregulation theory.
While Bronchogen's primary focus is respiratory health, its proposed mechanism of restoring cellular function has led to interest in its broader anti-aging and longevity potential. However, direct, robust evidence specifically for longevity effects in humans is still limited and primarily theoretical.
Historical and manufacturer-provided information suggests minimal and mild side effects for Bronchogen. However, comprehensive, independent safety data for broad populations is limited. As with any compound, individual reactions can vary, and allergic responses are possible.
Interaction risk for Bronchogen comes from the rest of the stack: other peptides, prescription medicines, hormone therapy and peptides. Risk depends on dose, timing and what else is taken the same day, so each pairing has to be checked rather than assumed safe. The free checker at https://doseroutine.com/interaction-checker covers Bronchogen with no sign-up.
Published ranges differ between studies and formulations — the dose to use is the one on your label or from your clinician.
There is no single answer for Bronchogen plus TRT. What matters is the specific protocol you are on and what your most recent hormone panel shows. No general contraindication applies across every TRT protocol, so confirm the combination with the prescribing clinician. See the free TRT interaction reference: https://doseroutine.com/trt-supplement-interactions
Pairing Bronchogen with peptides has to be assessed one peptide at a time, because GLP-1 agonists, secretagogues, healing peptides and melanocortins do not share an interaction profile. Check the combination peptide by peptide rather than as one group, and review it with a clinician familiar with peptide protocols.
Published frequency for Bronchogen varies by protocol and formulation, so the label or prescription is what sets it. Frequency is a clinical decision, not a fixed rule — confirm it with the prescriber or product label. Comparison of apps that keep a schedule like this: https://doseroutine.com/best-dose-tracking-apps
The effect of a missed dose of Bronchogen depends on the protocol and formulation you are on. Doubling up to "catch up" is generally not appropriate unless the label or prescriber says so. Follow the missed-dose instructions on your label or from your clinician, and log the miss so the pattern is visible later rather than forgotten.
For Bronchogen the useful record is the dose, the time it was actually taken, and what else was taken in the same window. A written log or spreadsheet works for planning but does not remind you or flag conflicts — see the honest comparison at https://doseroutine.com/vs/spreadsheet and the wider roundup at https://doseroutine.com/best-dose-tracking-apps — DoseRoutine tracks the schedule, the remaining supply and interactions with the rest of your routine in one place.
Which studies looked at Bronchogen?
Peer-reviewed research indexed in PubMed. Each entry links to the original record.
- 1.Effect of the peptide bronchogen (Ala-Asp-Glu-Leu) on DNA thermostability(opens PubMed in a new tab)Bull Exp Biol Med · 2011 · PMID 21240358 · https://pubmed.ncbi.nlm.nih.gov/21240358/
Sources cited on this page
Specific documents referenced by the numbered markers above. Each number matches the marker in the text.
- PubChem CID 11690869(opens in a new tab)National Center for Biotechnology Information · pubchem.ncbi.nlm.nih.gov/compound/11690869
Verify at
Publisher search links for Bronchogen. These are places to check the information — they are not citations, so they are not numbered.
- PubMed literature search(publisher search, opens in a new tab)National Library of Medicine · publisher search
- DailyMed labeling archive(publisher search, opens in a new tab)U.S. National Library of Medicine · publisher search
DoseRoutine compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician. How we source and review this information.
What is the short answer on Bronchogen?
Plain-text summary, safe to quote verbatim:
Bronchogen is a synthetic peptide known as a bioregulator, specifically designed to support the respiratory system. It belongs to a class of compounds developed in Russia by Professor V. Research on Bronchogen focuses on healthy aging. Dose, response, and interaction risk vary by individual, so use should be reviewed with a clinician.
Source: DoseRoutine — https://doseroutine.com/library/bronchogen
Bronchogen cheat sheet
DoseRoutine cheat sheet · Peptide
Bronchogen
Bronchogen is a synthetic peptide known as a bioregulator, specifically designed to support the respiratory system. It belongs to a class of compounds developed in Russia by Professor V.
Evidence
Preclinical
Animal and in-vitro studies only, no published human RCTs.
Not FDA-approvedResearch chemicalNot an FDA- or EMA-approved drugNo published human trials; evidence is limited to rat models and isolated-DNA/cell workLongevity
Studied ranges, not dosing advice. Not medical advice — talk to a clinician. doseroutine.com/library/bronchogen
Cite this page
Using this in an article, AI answer, or research note? Please attribute:
DoseRoutine. (2026). Bronchogen — Overview, Benefits & Side Effects. Retrieved from https://doseroutine.com/library/bronchogen
What compounds are similar to Bronchogen?
Others in the peptide category or studied for the same goals.
Which goals is Bronchogen used for?
Other compounds studied for the same benefits as Bronchogen.
Continue exploring
See every compound DoseRoutine catalogs for these goals.